NextCure, Inc. (NXTC)
6.39
+0.30
(+4.93%)
USD |
NASDAQ |
Aug 31, 16:00
6.26
-0.13
(-2.03%)
After-Hours: 07:17
NextCure Price : 6.39 for Aug. 31, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 31, 2026 | 6.13 | 6.580 | 6.078 | 6.39 | 54890.00 |
| Aug 28, 2026 | 5.98 | 6.20 | 5.930 | 6.09 | 60897.00 |
| Aug 27, 2026 | 5.95 | 6.34 | 5.932 | 6.035 | 73438.00 |
| Aug 26, 2026 | 5.85 | 6.19 | 5.60 | 5.83 | 92179.00 |
| Aug 25, 2026 | 5.93 | 6.759 | 5.84 | 5.91 | 160415.0 |
| Aug 24, 2026 | 6.20 | 6.629 | 5.69 | 5.89 | 121650.0 |
| Aug 21, 2026 | 6.19 | 6.58 | 6.19 | 6.29 | 36973.00 |
| Aug 20, 2026 | 6.55 | 6.725 | 6.00 | 6.25 | 86364.00 |
| Aug 19, 2026 | 6.72 | 7.26 | 6.60 | 6.78 | 157053.0 |
| Aug 18, 2026 | 7.47 | 7.80 | 6.51 | 6.65 | 257332.0 |
| Aug 17, 2026 | 8.17 | 8.285 | 7.58 | 7.71 | 184432.0 |
| Aug 14, 2026 | 8.13 | 8.39 | 7.54 | 8.21 | 262004.0 |
| Aug 13, 2026 | 8.24 | 8.66 | 7.83 | 8.28 | 286103.0 |
| Aug 12, 2026 | 6.75 | 8.72 | 6.60 | 8.17 | 493351.0 |
| Aug 11, 2026 | 6.52 | 6.92 | 6.46 | 6.73 | 181443.0 |
| Aug 10, 2026 | 6.16 | 7.167 | 5.91 | 6.84 | 1.395M |
| Aug 07, 2026 | 5.27 | 5.91 | 5.15 | 5.84 | 316114.0 |
| Aug 06, 2026 | 5.16 | 5.730 | 4.95 | 5.59 | 187400.0 |
| Aug 05, 2026 | 5.78 | 6.000 | 4.95 | 5.25 | 230247.0 |
| Aug 04, 2026 | 4.69 | 6.07 | 4.613 | 5.78 | 536285.0 |
| Aug 03, 2026 | 4.38 | 4.59 | 3.95 | 4.40 | 446614.0 |
| Jul 31, 2026 | 4.91 | 5.08 | 4.10 | 4.145 | 385707.0 |
| Jul 30, 2026 | 4.98 | 5.26 | 4.40 | 5.03 | 883090.0 |
| Jul 29, 2026 | 5.24 | 5.756 | 5.00 | 5.02 | 360110.0 |
| Jul 28, 2026 | 4.90 | 5.70 | 4.83 | 5.42 | 236313.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 82.39 |
| Oncolytics Biotech, Inc. | 0.8382 |
| Sangamo Therapeutics, Inc. | 0.1649 |
| Sarepta Therapeutics, Inc. | 21.03 |
| Anixa Biosciences, Inc. | 3.35 |
Price Related Metrics
| Price to Book Value | 2.140 |
| Earnings Yield | -165.7% |
| Market Cap | 26.00M |